Transcatheter device closure of post-myocardial infarction ventricular septal rupture: A single-centre experience

Praveen Chandra1, Nagendra Singh Chouhan1, Seenu Prasanth Adimoulame1

  • 1Heart Institute, Medanta - The Medicity, Sector 38, Gurugram, Haryana, 122001, India.

Indian Heart Journal
|April 5, 2026
PubMed

Insights

Transcatheter device closure for post-myocardial infarction ventricular septal rupture offers technical success but high early mortality. Patient survival depends on initial physiological status, highlighting the need for careful patient selection.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Post-myocardial infarction ventricular septal rupture is a rare, fatal complication.
  • Cardiogenic shock frequently complicates this condition, increasing mortality risk.

Purpose of the Study:

  • To evaluate the outcomes of transcatheter device closure in surgically declined patients with post-myocardial infarction ventricular septal rupture.
  • To identify factors associated with survival in this high-risk population.

Main Methods:

  • Single-centre retrospective cohort study.
  • Seventeen patients with post-myocardial infarction ventricular septal rupture underwent transcatheter device closure.
  • Data collected on technical success, early mortality, and survival predictors.

Main Results:

  • High technical success rate for device implantation.
  • Substantial early mortality (64.7%) with only 35.3% surviving beyond 30 days.
  • Deaths primarily due to refractory cardiogenic shock and multiorgan failure.

Conclusions:

  • Transcatheter device closure is technically feasible but associated with significant early mortality.
  • Lower SCAI shock stage, preserved lactate clearance, and higher arterial pH predict better survival.
  • Physiological status is critical for patient selection and outcomes in this critical condition.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
661
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
453